Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Apr 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022	Sep 30, 2021
Market Capitalization	11,879	9,785	8,290	2,716	2,659	3,324
Market Cap Growth	18.04%	18.04%	205.24%	2.14%	-20.00%	-5.41%
Enterprise Value	15,050	11,901	9,264	5,237	4,683	5,412
Last Close Price	2.78	2.29	1.94	1.43	1.40	1.68
PE Ratio	-	-	-	-	-	12.28
PS Ratio	2.66	2.19	3.75	0.93	0.98	1.09
PB Ratio	-51.66	-42.56	5.64	3.49	2.43	2.35
P/TBV Ratio	-	-	5.64	3.49	2.43	2.35
P/FCF Ratio	7.51	6.19	-	-	-	1693.09
P/OCF Ratio	5.20	4.28	-	20.49	-	9.61
EV/Sales Ratio	3.37	2.66	4.19	1.79	1.73	1.78
EV/EBITDA Ratio	14.26	11.28	-	54.54	49.41	8.47
EV/EBIT Ratio	16.28	12.87	-	-	-	9.86
EV/FCF Ratio	9.51	7.52	-	-	-	2756.94
Debt / Equity Ratio	-22.08	-22.08	2.87	4.68	3.05	2.15
Debt / EBITDA Ratio	4.81	4.81	-	35.20	35.15	4.64
Debt / FCF Ratio	3.21	3.21	-	-	-	1551.72
Asset Turnover	0.47	0.47	0.29	-	0.43	0.48
Inventory Turnover	1.22	1.22	0.79	-	1.02	1.12
Quick Ratio	0.36	0.36	0.43	0.48	0.63	1.53
Current Ratio	0.59	0.59	0.75	1.00	1.24	2.28
Return on Equity (ROE)	-274.21%	-274.21%	-254.91%	-	-8.74%	20.13%
Return on Assets (ROA)	6.13%	6.13%	-6.22%	-	-0.24%	5.41%
Return on Capital (ROIC)	10.98%	10.98%	-9.51%	-	-0.35%	7.60%
Return on Capital Employed (ROCE)	330.20%	330.20%	-	-	-	13.20%
Earnings Yield	-1430.46%	-17.36%	-34.56%	-11.97%	-4.12%	8.14%
FCF Yield	1331.57%	16.16%	-20.62%	-41.87%	-45.31%	0.06%
Dividend Yield	-	-	-	-	-	4.17%
Payout Ratio	-	-	-	-	-	45.62%
Buyback Yield / Dilution	-	-	-125.00%	-	-	-
Total Shareholder Return	-	-	-125.00%	-	-	4.17%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.